LIPELLA PHARMACEUTICALS INC.【LIPO】

Market cap

$781.79K

P/E ratio

	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Net Loss	-2,597,692	-4,618,965	-5,016,264
Depreciation and amortization	-	1,685	2,886
Shares issued for services	-	121,200	200,000
Non-cash stock option expense	747,396	1	749,396
Operating right of use asset	-	-	-599
Grants receivable	113,655	-81,369	52,427
Prepaid expense	470,175	-460,634	244,420
Accounts payable	337,456	-246,341	250,175
Accrued expenses	237,688	-315,525	160,606
Payroll liability	17,671	13,004	-100
Net cash used in operating activities	-1,831,161	-3,150,172	-3,950,747
Purchase of Property, plant and equipment	-	14,434	-
Net cash used in investing activities	300,546	-14,434	-
Proceeds from issuance of Preferred Stock, Common Stock and pre-funded warrants, net of issuance costs	-	-	3
Repayment of notes payable, related party	-	250,000	-
Repayment of notes payable	-	25,000	-
Net cash provided by financing activities	5	1	3
Net decrease in cash, cash equivalents	4	-1,828,005	-1,108,875
Interest paid	-	-	11,908
Income taxes paid	-	-11,358	-
Issuance Common Stock options for consulting services	-	121,200	-